Read More Analyst Ratings News Price Target Piper Sandler Maintains Overweight on Okta, Raises Price Target to $90 By Benzinga Newsdesk Today, 8:22 AM Piper Sandler analyst Rob Owens maintains Okta (NASDAQ:OKTA) with a Overweight and raises the price target from $80 to $90. OKTA
Read More News Short Sellers ‘A $2 billion market with high 20% market share and prices dropping 20% is a big hole for $GNRC to fill….’ -Spruce Point Capital By Benzinga Newsdesk Today, 8:22 AM https://twitter.com/sprucepointcap/status/1539597328339898368 GNRC
Read More Analyst Ratings Biotech General Health Care Long Ideas Movers News Reiteration Trading Ideas B. Riley Says Alzheimer’s Data From This Firm Has Renewed ‘Investor Confidence’ By Vandana Singh Today, 8:22 AM B. Riley says yesterday's readout from a pre-planned 12-month treatment interim analysis of Cassava Sciences Inc's (NASDAQ: SAVA) simufilam trial data "reinvigorate" investor confidence. SAVA
Read More Analyst Ratings Initiation News Price Target Jefferies Initiates Coverage On UWM Holdings with Hold Rating, Announces Price Target of $9.5 By Benzinga Newsdesk Today, 8:22 AM Jefferies analyst Ryan Carr initiates coverage on UWM Holdings (NYSE:UWMC) with a Hold rating and announces Price Target of $9.5. UWMC